<--- Back to Details
First PageDocument Content
Maraviroc / Darunavir / Atazanavir / Antiretroviral drug / Lopinavir/ritonavir / Ritonavir / Efavirenz / Saquinavir / Etravirine / Chemistry / Organic chemistry / Protease inhibitors
Date: 2014-06-20 13:58:48
Maraviroc
Darunavir
Atazanavir
Antiretroviral drug
Lopinavir/ritonavir
Ritonavir
Efavirenz
Saquinavir
Etravirine
Chemistry
Organic chemistry
Protease inhibitors

Microsoft Word - CCR5-int

Add to Reading List

Source URL: www.hivclinic.ca

Download Document from Source Website

File Size: 86,48 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 17saC - View Document

2011 Bull, R.A., J. Hyde, J. M. Mackenzie, G.S. Hansman, T. Oka, N. Takeda and P.A. White[removed]Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes. 42:16-

2011 Bull, R.A., J. Hyde, J. M. Mackenzie, G.S. Hansman, T. Oka, N. Takeda and P.A. White[removed]Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes. 42:16-

DocID: 11sCt - View Document

Publications 2013 Mark Gorrell Journal Article Diabetes and Non-alcoholic Fatty Liver Disease – A Pathogenic Duo’ Williams, KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM, Endocrine Reviews 2013 Feb;34(1):[removed]B

Publications 2013 Mark Gorrell Journal Article Diabetes and Non-alcoholic Fatty Liver Disease – A Pathogenic Duo’ Williams, KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM, Endocrine Reviews 2013 Feb;34(1):[removed]B

DocID: 11pY5 - View Document

2010  Bull, R. A., J-S. Eden, W. D. Rawlinson and P. A. White[removed]Rapid Evolution of Pandemic Noroviruses of the GII.4 lineage. PLoS Pathogens. 6: e1000831. Gorry, P.R., A. Ellett, and S.R. Lewin[removed]Maraviroc. I

2010 Bull, R. A., J-S. Eden, W. D. Rawlinson and P. A. White[removed]Rapid Evolution of Pandemic Noroviruses of the GII.4 lineage. PLoS Pathogens. 6: e1000831. Gorry, P.R., A. Ellett, and S.R. Lewin[removed]Maraviroc. I

DocID: 10prU - View Document

Consultation Decision Analytic Protocol to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

Consultation Decision Analytic Protocol to guide the assessment of a pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

DocID: VMeV - View Document